Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2190 participants.
Also called NCT06855537
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,190 participants
- Sponsor
- Registry
-
NCT06855537
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06855537. Randomized; no masking; primary purpose prevention. Start 2025-11-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
- Condition
- Coronary Arterial Disease (CAD (coronary artery disease))
- Condition
- Vulnerable Coronary Plaques
- Condition
- Thin-cap fIbroatheroma
- Condition
- Acute Coronary Syndromes (ACS)
- Intervention (Procedure)
- PCI (percutaneous coronary intervention) strategy
- Intervention (Drug)
- OMT strategy
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct06855537- Content hash
2519044f0c60eb439c3002a4b88655d96ad88e5db1fc67e55307f779a0f02fbd